Literature DB >> 11520568

Minimal regions of chromosomal imbalance in retinoblastoma detected by comparative genomic hybridization.

D Chen1, B L Gallie, J A Squire.   

Abstract

Mutation of both alleles of the retinoblastoma gene (RB1) initiate oncogenesis in developing human retina, but other common genomic alterations are present in the tumors. In order to sublocalize the altered genomic regions, 50 retinoblastoma tumors were examined by comparative genomic hybridization (CGH). The minimal regions most frequent gained were 1q31 (52%), 6p22 (44%), 2p24-p25 (30%) and 13q32-q34 (12%). The minimal region most frequently lost was 16q22 (14%). The overall total number of gains or losses evident on CGH was significantly greater in those tumors with either or both 6p or 1q gain, than in tumors with neither 6p nor 1q gain suggesting that chromosomal instability may be associated with acquisition of these changes. Genes mapping to 6p22 and 1q31 may be important in tumor development in retina subsequent to the loss of RB1 alleles.

Entities:  

Mesh:

Year:  2001        PMID: 11520568     DOI: 10.1016/s0165-4608(01)00427-7

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  25 in total

Review 1.  Chromosome 6p amplification and cancer progression.

Authors:  Gda C Santos; M Zielenska; M Prasad; J A Squire
Journal:  J Clin Pathol       Date:  2006-06-21       Impact factor: 3.411

2.  Expression of multidrug resistance proteins in retinoblastoma.

Authors:  Swati Shukla; Arpna Srivastava; Sunil Kumar; Usha Singh; Sandeep Goswami; Bhavna Chawla; Mandeep Singh Bajaj; Seema Kashyap; Jasbir Kaur
Journal:  Int J Ophthalmol       Date:  2017-11-18       Impact factor: 1.779

3.  Chromosome 6p Amplification in Aqueous Humor Cell-Free DNA Is a Prognostic Biomarker for Retinoblastoma Ocular Survival.

Authors:  Liya Xu; Ashley Polski; Rishvanth K Prabakar; Mark W Reid; Patricia Chevez-Barrios; Rima Jubran; Jonathan W Kim; Peter Kuhn; David Cobrinik; James Hicks; Jesse L Berry
Journal:  Mol Cancer Res       Date:  2020-05-20       Impact factor: 5.852

4.  Coordinated repression of cell cycle genes by KDM5A and E2F4 during differentiation.

Authors:  Michael L Beshiri; Katherine B Holmes; William F Richter; Samuel Hess; Abul B M M K Islam; Qin Yan; Lydia Plante; Larisa Litovchick; Nicolas Gévry; Nuria Lopez-Bigas; William G Kaelin; Elizaveta V Benevolenskaya
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-23       Impact factor: 11.205

5.  Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis.

Authors:  Jian-Jun Zhao; Juhua Yang; Jianhong Lin; Nan Yao; Yihua Zhu; Jianlong Zheng; Jianhua Xu; Jin Q Cheng; Jian-Yin Lin; Xu Ma
Journal:  Childs Nerv Syst       Date:  2008-09-26       Impact factor: 1.475

6.  Cdh11 acts as a tumor suppressor in a murine retinoblastoma model by facilitating tumor cell death.

Authors:  Mellone N Marchong; Christine Yurkowski; Clement Ma; Clarellen Spencer; Sanja Pajovic; Brenda L Gallie
Journal:  PLoS Genet       Date:  2010-04-22       Impact factor: 5.917

7.  Molecular karyotype of sporadic unilateral retinoblastoma tumors.

Authors:  Arupa Ganguly; Kim E Nichols; Gregory Grant; Eric Rappaport; Carol Shields
Journal:  Retina       Date:  2009 Jul-Aug       Impact factor: 4.256

8.  Comparative genomic hybridisation divides retinoblastomas into a high and a low level chromosomal instability group.

Authors:  J E van der Wal; M A J A Hermsen; H J P Gille; N Y N Schouten-Van Meeteren; A C Moll; S M Imhof; G A Meijer; J P A Baak; P van der Valk
Journal:  J Clin Pathol       Date:  2003-01       Impact factor: 3.411

9.  Cell type-specific effects of Rb deletion in the murine retina.

Authors:  David MacPherson; Julien Sage; Teresa Kim; Dennis Ho; Margaret E McLaughlin; Tyler Jacks
Journal:  Genes Dev       Date:  2004-07-01       Impact factor: 11.361

Review 10.  Emerging roles of E2Fs in cancer: an exit from cell cycle control.

Authors:  Hui-Zi Chen; Shih-Yin Tsai; Gustavo Leone
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.